GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (NAS:ABCM) » Definitions » Research & Development

Abcam (ABCM) Research & Development : $69.8 Mil (TTM As of Jun. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Abcam Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Abcam's Research & Development for the six months ended in Jun. 2023 was $24.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was $69.8 Mil.

Abcam Research & Development Historical Data

The historical data trend for Abcam's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Research & Development Chart

Abcam Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.82 15.82 19.01 47.94 68.33

Abcam Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.11 11.36 23.52 45.07 24.75

Abcam Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $69.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abcam  (NAS:ABCM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Abcam Research & Development Related Terms

Thank you for viewing the detailed overview of Abcam's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (ABCM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (NAS:ABCM) » Definitions » Research & Development
Comparable Companies
ACAD CRSP HALO RVMD BPMC NUVL MDGL INSM PCVX FOLD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
N/A
Address
Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX
Website
https://www.abcam.com
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.